Morgan Stanley Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $62.84 -1.19%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Join SI Premium – FREE
Morgan Stanley downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- Buy the pullback in this large pharma stock: UBS
- Goldman Sachs Downgrades Fluence Energy Inc. (FLNC) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
